AE37 Vaccine Trial - for recently treated high-risk patients

TectonicShift
TectonicShift Member Posts: 752
edited June 2014 in Stage III Breast Cancer

I want to make sure everyone here in stage 3 knows about the phase II AE37 vaccine trial that's going on right now. You can enroll in the trial if you are at least one month out from end of standard treatment (radiation or Herceptin), but not more than six months out.

Many types of breast cancer are eligible: ER+, ER-, HER2+, HER2-, male, female, node positive and high-risk node negative, up to stage 3C.

You can't be HER2-0 (HER2 zero). You have to be either HER2-1+, HER2-2+, or HER2-3+.

(Please note, only HER2-3+ is considered "HER2 positive." HER2-0, HER2-1+, and HER2-2+ are all considered "HER2 negative." You cannot be HER2-zero; you have to be at least HER2-1+ for this trial.)

You do have to travel to one of the trial sites every month for six months, and then every six months for the next two years. The first time, you have to be there for a whole week, because you have appointments Monday, Tuesday, Wednesday, and Friday-- for testing and such. After that, appointments are Monday and Wednesday, or Wednesday and Friday, once a month, for six months. 

Non-military sites are in Washington (DC), Baltimore, Honolulu, Winston-Salem, Texas, and Greece.

Military sites (open to military personnel only) are in Texas, Tacoma, Bethesda, and Landstuhl Germany.

Here is the trial sheet that lists the exact locations where the trial is being offered and other specifics: http://clinicaltrials.gov/ct2/show/NCT00524277?term=ae37&rank=1 

Results look very good so far: http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=125&abstractID=102964

I'm in the trial. PM me if you have questions. 

· Share on FacebookShare on Twitter
«13456

Comments

Categories